Innovation & IP Asset Consulting
Convergence for divergent trends

MEDICAL ENGINEERING COMPANY MEDTRONIC TAKES OVER COVIDIEN

Medtronic takes over its American competitor Covidien for approximately 43 billion U.S. dollars, whose shares thereupon increased by more than 27%. This fusion would in particular be an extension of the two companies. While Medtronic specializes in heart disease, Covidien focuses particularly on minimally invasive (keyhole) surgery, vascular therapy and patient monitoring. The enormous austerity of many health systems forces medical engineering companies to find more new efficient synergies through mergers. A strategy is therefore currently pursued, to offer Hospitals themselves. With a combined turnover of 27 billion U.S. dollars, the top position of the pharmaceutical and medical engineering giant Johnson & Johnson is attacked.